References
- Choo QL, Kuo G, Wener AJ, Overby RL, Bradley DW, Hougton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362
- Esteban J, Esteban R, Villadomiu L, Lopez-Talavera JC, Gonzales A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, Guardia J. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–296
- Roggendorfer M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, Zachoval R, Pape G, Schramm W, Rommel F. Antibodies to hepatitis C virus. Lancet 1989; 2: 234–325
- Mortimer PP, Cohen BJ, Litton PA, Van der Velde EM, Bassendine MF, Brinde AM, Hambling MH. Hepatitis C virus antibody. Lancet 1989; 2: 798
- Sirchia G, Italian Group for the Proper Use of Blood. Prevalence of anti-HCV antibodies in Italian blood donors. Read before the First International Meeting on hepatitis C virus, Rome, 1989, September 14–15, 1989
- Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny KD, Rogers M, Feiner C, Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989; 321: 874–879
- Melbye M, Biggar RJ, Wantzin P, Krogsgaard K, Ebbesen P, Becker NG. Sexual transmission of hepatitis C virus: cohort study (1981–89) among European homosexual men. Br Med J 1990; 301: 210–212